Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Deferred Tax Assets / Liabilities ₹15 Cr₹14 Cr₹7.26 Cr₹10 Cr₹5.78 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA is ₹15 Cr based on Mar2023 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2023₹15 Cr
Mar2022₹14 Cr
Mar2021₹7.26 Cr
Mar2020₹10 Cr
Mar2019₹5.78 Cr

How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2023 ₹15 Cr
11.78
Mar2022 ₹14 Cr
89.48
Mar2021 ₹7.26 Cr
-28.50
Mar2020 ₹10 Cr
75.75
Mar2019 ₹5.78 Cr -

Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,634.2 Cr 1% 0.4% 137.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,673.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,930.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹109,446.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹108,261.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,830.6 Cr 0.9% -1.5% 32.2% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

1%

0.4%

137.6%

SENSEX

2%

2.3%

22.2%


You may also like the below Video Courses